by Vandana Singh | Feb 12, 2026 | General
Novo Nordisk A/S (NYSE:NVO) plans to start selling its blockbuster obesity drug Wegovy in vials, marking its latest effort to strengthen its position against rival Eli Lilly and Co. (NYSE:LLY) as competition intensifies in the fast-growing weight-loss market....
by Evette Mitkov | Feb 12, 2026 | General
Oscar Health Inc (NYSE:OSCR) shares are climbing on Thursday. The company posted fourth‑quarter results that missed expectations on both revenue and earnings, but had a stronger‑than‑expected 2026 outlook. Oscar Health stock is gaining positive traction. Why are OSCR...
by Akanksha Bakshi | Feb 12, 2026 | General
Restaurant Brands International Inc. (NYSE:QSR), parent company of Tim Hortons’ and Burger King, reported Thursday results for the fourth quarter and full year 2025. Total revenue rose to $2.466 billion in the quarter from $2.296 billion a year earlier and to $9.434...
by Akanksha Bakshi | Feb 12, 2026 | General
US Foods Holding Corp. (NYSE:USFD) on Thursday reported fourth-quarter and full-year fiscal 2025 results and issued fiscal 2026 guidance, delivering an earnings beat and strong margin performance that lifted investor sentiment. For the fourth quarter, adjusted diluted...
by Vandana Singh | Feb 12, 2026 | General
BridgeBio Pharma Inc. (NASDAQ:BBIO) stock is surging on Thursday and nearing the upper end of its 52-week range of $28.33-$84.94, according to Benzinga Pro data. The biopharmaceutical company focused on genetic conditions, shared positive topline results from PROPEL 3...
Recent Comments